Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer
Michael Rink(Marienkrankenhaus Hamburg), Shahrokh F. Shariat(Universitätszahnklinik Wien), Helena Furberg(Memorial Sloan Kettering Cancer Center), Yair Lotan(Southwestern Medical Center), Giacomo Novara(University of Padua), Douglas S. Scherr(Cornell University), Emily C. Zabor(Cleveland Clinic), Brian D. Robinson(Cornell University), Francesco Montorsi(Vita-Salute San Raffaele University), Pierre I. Karakiewicz(Université de Montréal), Armin Pycha(Sigmund Freud Privatuniversität Wien), Felix K.‐H. Chun(Universität Hamburg), Marko Babjuk(Charles University), Évanguelos Xylinas(NewYork–Presbyterian Hospital)
Cited by 133
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359
Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination
|Clinical Cancer Research|2009|351